Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHUTCHMED (China) Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q2 2025 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q3 2025 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2025 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q1 2026 | 1 | -$1.23 | -$1.23 | -$1.23 |
| Q2 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q3 2026 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q4 2026 | 1 | -$1.23 | -$1.23 | -$1.23 |
| Q1 2027 | 1 | $0.04 | $0.04 | $0.04 |
| Q2 2027 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q1 2028 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2028 | 1 | -$0.06 | -$0.06 | -$0.06 |
HUTCHMED (China) Limited Earnings Date And Information
HUTCHMED (China) Limited last posted its earnings results on Wednesday, February 28th, 2024. The company reported $-0.03975 earnings per share for the quarter, topping analysts' consensus estimates of $-1.08 by $1.04025. The company had revenue of 152.84 M for the quarter and had revenue of 838.00 M for the year. HUTCHMED (China) Limited has generated $0 earnings per share over the last year ($0.116 diluted earnings per share) and currently has a price-to-earnings ratio of -63.94. HUTCHMED (China) Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
HUTCHMED (China) Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/31/2024 | Q2 2024 | N/A | $0.02 | N/A | $319.35 M | $152.84 M |
| 02/28/2024 | Q1 2024 | -$1.08 | $0.02 | 1.1 | N/A | $152.84 M |
| 02/28/2024 | Q4 2023 | -$1.08 | -$0.04 | 1.04 | N/A | $152.56 M |
| 09/28/2023 | Q3 2023 | N/A | -$0.04 | N/A | N/A | $152.56 M |
| 07/31/2023 | Q2 2023 | N/A | $0.10 | N/A | N/A | $266.44 M |
| 02/28/2023 | Q1 2023 | -$1.02 | $0.10 | 1.12 | N/A | $266.44 M |
| 02/28/2023 | Q4 2022 | -$1.02 | -$0.12 | 0.9 | N/A | $112.18 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.12 | N/A | N/A | $112.18 M |
| 08/01/2022 | Q2 2022 | N/A | -$0.19 | N/A | N/A | $202.05 M |
| 03/03/2022 | Q1 2022 | -$0.73 | -$0.10 | 0.63 | N/A | $101.02 M |
| 03/03/2022 | Q4 2021 | -$0.73 | -$0.03 | 0.7 | N/A | $138.16 M |
| 09/29/2021 | Q3 2021 | N/A | -$0.05 | N/A | N/A | $99.38 M |
| 03/04/2021 | Q2 2021 | -$0.23 | -$0.11 | 0.12 | N/A | $75.81 M |
| 03/04/2021 | Q1 2021 | -$0.23 | -$0.09 | 0.14 | N/A | $81.56 M |
| 03/04/2021 | Q4 2020 | -$0.23 | -$0.05 | 0.18 | N/A | $60.61 M |
| 09/29/2020 | Q3 2020 | N/A | -$0.05 | N/A | N/A | $60.61 M |
| 03/03/2020 | Q2 2020 | N/A | -$0.05 | N/A | N/A | $55.20 M |
| 01/21/2020 | Q1 2020 | -$0.17 | -$0.02 | 0.15 | N/A | $51.57 M |
| 03/03/2020 | Q4 2019 | N/A | -$0.06 | N/A | N/A | $52.84 M |
| 07/30/2019 | Q3 2019 | -$0.15 | -$0.05 | 0.1 | N/A | $49.35 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
HUTCHMED (China) Limited Earnings: FAQ's
HUTCHMED (China) Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
In the previous quarter, HUTCHMED (China) Limited (:HCM) reported $-0.03975 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.08 by $1.04025.
The conference call for HUTCHMED (China) Limited's latest earnings report can be listened to online.
The conference call transcript for HUTCHMED (China) Limited's latest earnings report can be read online.
HUTCHMED (China) Limited (:HCM) has a recorded annual revenue of $838.00 M.
HUTCHMED (China) Limited (:HCM) has a recorded net income of $100.78 M.HUTCHMED (China) Limited has generated $0.118 earnings per share over the last four quarters.
HUTCHMED (China) Limited (:HCM) has a price-to-earnings ratio of -63.94 and price/earnings-to-growth ratio is 0.24.